Prospective Cohort Study on the Preventive Effect of Chinese Medicine Prescription of Close Contact Crowd with Winter Influenza

Phase 1

• Conditions: Influenza

• Registration Number: ITMCTR2200005602
• Lead Sponsor: Dongzhimen Hospital of Beijing University of Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1) Age 18-75 years old;
2) The case collection period is from November to March of the following year. During this trial period, patients who were clinically diagnosed with influenza in the emergency department outpatient department or respiratory department outpatient department, their family members, roommates and other close contacts living together;
3) Voluntarily participate in the trial and sign the informed consent.

Exclusion Criteria

1) Patients who have developed flu-like symptoms, or patients who require/undergo antibiotics and antiviral drug treatment interventions;
2) Those who have been injected with influenza vaccine or take other Chinese medicines and Chinese patent medicines to prevent influenza;
3) Pregnant or lactating women;
4) Patients with severe heart, liver, renal insufficiency or other serious diseases;
5) Those who are known to be allergic to traditional Chinese medicine ingredients.

Study & Design

• Study Type: Prevention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Influenza A/B Rapid Screening Test;

Secondary Outcome Measures

Name	Time	Method
Detection of T lymphocyte subsets;